Filing Details

Accession Number:
0001062359-16-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-03 14:58:13
Reporting Period:
2016-02-02
Filing Date:
2016-02-03
Accepted Time:
2016-02-03 14:58:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1016708 Renovacare Inc. RCAR Oil & Gas Field Exploration Services (1382) 980170247
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1062359 S Harmel Rayat 700 - 688 West Hastings Street
Vancouver A1 V6B 1P1
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.00001 Acquisiton 2016-02-02 2,173,913 $0.46 44,550,713 No 4 P Indirect Kalen Capital Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Kalen Capital Corporation
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.00001 Series B Stock Purchase Warrant Disposition 2016-02-02 2,173,913 $0.46 1,326,087 $0.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,626,087 2013-11-29 2018-11-29 No 4 C Indirect
Footnotes
  1. On February 2, 2016, Kalen Capital Corporation exercised a Series B Stock Purchase Warrant for 2,173,913 shares of Issuers common stock at an exercise price of $0.46 per share for payment of $999,999.98.
  2. Does not include derivative securities beneficially owned by Mr. Rayat.
  3. Mr. Rayat is the sole shareholder and sole director of Kalen Capital Corporation.
  4. Represents the number of shares remaining issuable upon exercise of the Series B Stock Purchase Warrant.
  5. Includes (a) a Series B Stock Purchase Warrant to purchase up to 1,326,087 shares of the Issuers common stock at an exercise price of $0.46 per share through November 29, 2018; (b) a Series C Stock Purchase Warrant to purchase up to 3,500,000 shares of the Issuers common stock at an exercise price of $0.49 per share through November 29, 2018; and (c) a Series D Stock Purchase Warrant to purchase up to 800,000 shares of the Issuers common stock at an exercise price of $1.10 per share through June 5, 2020. Each of the foregoing warrants may be exercised on a cashless basis.